Substance / Medication

Caspofungin acetate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

7 trials linked to this intervention

7
Total Trials
0
Recruiting
5
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Safety and tolerability of caspofungin acetate in the treatment of fungal infections.
Sable C A, Nguyen B-Y T, Chodakewitz J A et al. · Transpl Infect Dis · 2002
PMID: 12123423Observational
Successful treatment of liver aspergilloma by caspofungin acetate first-line therapy in a non-immunocompromised patient.
Bai Qing-Xian, Huan Yi, Wang Jian-Hong et al. · Int J Mol Sci · 2012
PMID: 23109838Case ReportFull text (PMC)
Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent.
McGee William T, Tereso Gary J · Crit Care Med · 2003
PMID: 12771636Case Report
Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate.
Goodman Daniel, Pamer Eric, Jakubowski Ann et al. · Clin Infect Dis · 2002
PMID: 12115115Case Report
Ionto phoretic delivery of caspofungin acetate to the cornea and sclera and its intracorneal biodistribution.
González Iglesias Laura Gisela, Kalia Yogeshvar N · Int J Pharm X · 2025
PMID: 41362441OtherFull text (PMC)
Pharmacokinetics of caspofungin acetate to guide optimal dosing in cats.
Leshinsky Jana, McLachlan Andrew, Foster David J R et al. · PLoS One · 2017
PMID: 28575121PreclinicalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Caspofungin acetate (substance)
SNOMED CT
129474002
UMLS CUI
C0935942

Clinical Data

This intervention maps to 3 entities in the Healos knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
7
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.